TY - JOUR
T1 - The evolution of field deployable fNIR spectroscopy from bench to clinical settings
AU - Izzetoglu, Kurtulus
AU - Ayaz, Hasan
AU - Merzagora, Anna
AU - Izzetoglu, Meltem
AU - Shewokis, Patricia A.
AU - Bunce, Scott
AU - Pourrezaei, Kambiz
AU - Rosen, Arye
AU - Onaral, Banu
N1 - Funding Information:
We acknowledge with thanks Dr. Shoko Nioka for her support and guidance throughout the development of technology; Drs. George Mychaskiw, Harel Rosen, Jay Horrow, Jose Leon-Carrion, and Maria Schultheis for their leadership, support, and guidance during the clinical studies; Ajit Devaraj, Alper Bozkurt, Frank Kepics, Gunay Yurtsever, and Mauricio Rodriguez for their hardware support in helping to develop various fNIR systems. These studies have been sponsored in part by funds from the Defense Advanced Research Projects Agency (DARPA) Augmented Cognition Program and the O±ce of Naval Research (ONR), under agreement numbers N00014-02-1-0524 and N00014-01-1-0986; Wallace H. Coulter Foundation, U.S. Army Medical Research Acquisition Activity; Cooperative Agreement W81XWH-08-2-0573.
PY - 2011/7
Y1 - 2011/7
N2 - In the late 1980s and early 1990s, Dr. Britton Chance and his colleagues, using picosecond-long laser pulses, spearheaded the development of time-resolved spectroscopy techniques in an effort to obtain quantitative information about the optical characteristics of the tissue. These efforts by Chance and colleagues expedited the translation of near-infrared spectroscopy (NIRS)-based techniques into a neuroimaging modality for various cognitive studies. Beginning in the early 2000s, Dr. Britton Chance guided and steered the collaboration with the Optical Brain Imaging team at Drexel University toward the development and application of a field deployable continuous wave functional near-infrared spectroscopy (fNIR) system as a means to monitor cognitive functions, particularly during attention and working memory tasks as well as for complex tasks such as war games and air traffic control scenarios performed by healthy volunteers under operational conditions. Further, these collaborative efforts led to various clinical applications, including traumatic brain injury, depth of anesthesia monitoring, pediatric pain assessment, and braincomputer interface in neurology. In this paper, we introduce how these collaborative studies have made fNIR an excellent candidate for specified clinical and research applications, including repeated cortical neuroimaging, bedside or home monitoring, the elicitation of a positive effect, and protocols requiring ecological validity. This paper represents a token of our gratitude to Dr. Britton Chance for his influence and leadership. Through this manuscript we show our appreciation by contributing to his commemoration and through our work we will strive to advance the field of optical brain imaging and promote his legacy.
AB - In the late 1980s and early 1990s, Dr. Britton Chance and his colleagues, using picosecond-long laser pulses, spearheaded the development of time-resolved spectroscopy techniques in an effort to obtain quantitative information about the optical characteristics of the tissue. These efforts by Chance and colleagues expedited the translation of near-infrared spectroscopy (NIRS)-based techniques into a neuroimaging modality for various cognitive studies. Beginning in the early 2000s, Dr. Britton Chance guided and steered the collaboration with the Optical Brain Imaging team at Drexel University toward the development and application of a field deployable continuous wave functional near-infrared spectroscopy (fNIR) system as a means to monitor cognitive functions, particularly during attention and working memory tasks as well as for complex tasks such as war games and air traffic control scenarios performed by healthy volunteers under operational conditions. Further, these collaborative efforts led to various clinical applications, including traumatic brain injury, depth of anesthesia monitoring, pediatric pain assessment, and braincomputer interface in neurology. In this paper, we introduce how these collaborative studies have made fNIR an excellent candidate for specified clinical and research applications, including repeated cortical neuroimaging, bedside or home monitoring, the elicitation of a positive effect, and protocols requiring ecological validity. This paper represents a token of our gratitude to Dr. Britton Chance for his influence and leadership. Through this manuscript we show our appreciation by contributing to his commemoration and through our work we will strive to advance the field of optical brain imaging and promote his legacy.
UR - http://www.scopus.com/inward/record.url?scp=79960796775&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960796775&partnerID=8YFLogxK
U2 - 10.1142/S1793545811001587
DO - 10.1142/S1793545811001587
M3 - Review article
AN - SCOPUS:79960796775
SN - 1793-5458
VL - 4
SP - 239
EP - 250
JO - Journal of Innovative Optical Health Sciences
JF - Journal of Innovative Optical Health Sciences
IS - 3
ER -